$24M sweet spot round size
Most of their 9 investments are in rounds between $8.1M and $50M
1984
Roivant Sciences raised $200M on October 1, 2021
Investors: Suvretta Capital Management LLC, Patient Square Capital, Palantir Technologies, Viking Global Investors, Eventide Asset Management, RTW Investments, LP and Dainippon Sumitomo Pharma
Myovant Sciences raised $200M on August 5, 2020
Investors: Dainippon Sumitomo Pharma
Drawbridge Health raised undisclosed on July 24, 2019
Investors: GE Ventures and Dainippon Sumitomo Pharma
Undisclosed raised $8.1M on April 5, 2019
Investors: SMBCベンチャーキャピタル(株), Kyoto University Innovation Capital Co., Ltd, NVCC and Dainippon Sumitomo Pharma
株式会社メルティンMMI raised $18M on October 17, 2018
Investors: SBI Investment, The Dai-ichi Life Insurance Company, Limited and Dainippon Sumitomo Pharma
FunPep Co., Ltd. raised $4M on October 5, 2018
Investors: バイオ・サイト・キャピタル(株), Morishita Jintan Co Ltd, Shionogi & Co., Ltd and Dainippon Sumitomo Pharma
Undisclosed raised $8.3M on May 22, 2014
Investors: 日本ビーシージー製造株式会社, Innovation Network Corporation Of Japan and Dainippon Sumitomo Pharma
Edison Pharmaceuticals raised $50M on March 27, 2014
Investors: Dainippon Sumitomo Pharma
Healios K.K. raised $31M on October 8, 2013
Investors: SNBL USA, Dogan, Inc. and Dainippon Sumitomo Pharma